General Information of the Compound
Compound ID |
CP0061272
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N(alpha)-Methylhistamine
Show/Hide
|
||||||||||||||||||
Synonyms |
1H-Imidazole-4-ethanamine, N-methyl-
2-(3H-imidazol-4-yl)-N-methylethanamine
4-(2-Methylaminoethyl)imidazole
Imidazole, 4-(2-(methylamino)ethyl)-
Imidazole, 4-[2-(methylamino)ethyl]-
N(alpha)-methylhistamine
N(sup alpha)-Methylhistamine
N-[3H]alpha-methylhistamine
N-alpha-methyl histamine
N-alpha-methylhistamine
NAMH
Nalpha-Methylhistamine
UNII-Y7QR253130
Y7QR253130
[2-(1H-imidazol-5-yl)ethyl](methyl)amine
[3H]-Na-methylhistamine
[3H]NAMH
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C6H11N3
|
||||||||||||||||||
Molecular Weight |
125.175
|
||||||||||||||||||
Canonical SMILES |
CNCCc1cnc[nH]1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C6H11N3/c1-7-3-2-6-4-8-5-9-6/h4-5,7H,2-3H2,1H3,(H,8,9)
Show/Hide
|
||||||||||||||||||
InChIKey |
PHSPJQZRQAJPPF-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
673-50-7
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT03665, Histamine H3 receptor
Protein ID: PT01711, Histamine H4 receptor
Clinical Information about the Compound